好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Analysis of Post-discharge Deaths In a Zambian Stroke Cohort
Cerebrovascular Disease and Interventional Neurology
P9 - Poster Session 9 (5:00 PM-6:00 PM)
5-010
To identify the factors that contribute to the high post discharge mortalities in a Zambia stroke cohort.
Improving post-discharge outcomes for people with stroke requires an
understanding of adverse events that occur during this period. We identified
causes of death amongst adults with stroke in Zambia.
We conducted a prospective cohort study of individuals with stroke admitted
to the University Teaching Hospital in Lusaka. Patients were called every
three months post-discharge for one year, and vital status was ascertained. 
For those who died, caregivers were asked to answer questions on
symptoms prior to and circumstances of death and cause of death as the
caregiver understood it. Of note, adjudication of causes of death was not
possible.
83 deaths occurred during the post-discharge period. Causes of death were
provided for 68 (82%) and comprised of complications of stroke (25%, n=17), 
recurrent stroke (18%, n=12),aspiration pneumonia (16%, n=11), cardiac
disease (7%, n=5), kidney failure (7%, n=5), decubitus ulcers (4%, n=3), 
sepsis (4%, n=3), poorly controlled hypertension (4%, n=3), diabetes (4%, 
n=3), failure to feed (3%, n=2), anemia (3%, n=2), COVID (1%, n=1), and liver
failure (1%, n=1). Nearly one-quarter (n=19, 23%) of participants developed
new or distressing symptoms prior to death, including refractory
hypertension, decubitus ulcers, heart disease, deep vein thrombosis, kidney
failure, insomnia, failure to thrive, severe headache, hypotension, 
uncontrolled pain, and diarrhea. Half of deaths (n=25, 49%) occurred at
home because caregivers reported deaths were sudden or unexpected.
Nearly two-thirds of post-discharge deaths were preventable, and three- 
quarters of distressing end-of-life symptoms were preventable and/or
manageable with adequate medical care. A high percentage of at-home
deaths potentially suggests caregivers are unaware of warning signs of
deterioration or when to seek care. Improving post-discharge medical services for individuals with stroke could substantially improve long-term stroke outcomes in Zambia.
Authors/Disclosures
William Tembo, MD
PRESENTER
An immediate family member of Mr. Tembo has received research support from City University of New York (CUNY).
Michael Kinkata, MD Michael Kinkata, MD has nothing to disclose.
Aparna Nutakki, MD Ms. Nutakki has received research support from UJMT Fogarty Global Health Fellowship Program. Ms. Nutakki has received research support from AAN Medical Student Research Scholarship. Ms. Nutakki has received research support from Gold Humanism Student Summer Fellowship.
Sarah Braun, MD (University Teaching Hospital, Lusaka, Zambia) Sarah Braun has nothing to disclose.
Melody T. Asukile, MBBS (University Teaching Hospital) Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. The institution of Dr. Asukile has received research support from Leverhulme Trust. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Lorraine Chishimba, MBChB, MMED (University Teaching Hospital) Dr. Chishimba has nothing to disclose.
Mulenga Chilando (University Teaching Hospital) Mulenga Chilando has nothing to disclose.
Mashina Chomba, MBChB (University of Zambia) Dr. Chomba has nothing to disclose.
Musisye Luchembe Musisye Luchembe has nothing to disclose.
Dominique Mortel, MD (Phoebe Neurology) Dr. Mortel has nothing to disclose.
Dickson Munkombwe, MD (University Teaching Hospital - Adult Hospital) Dr. Munkombwe has nothing to disclose.
Julia Mwamba (University Teaching Hopsital) Julia Mwamba has nothing to disclose.
Naluca Mwendaweli, MMED (University Teaching Hospital) NALUCA MWENDAWELI has nothing to disclose.
Frighton B. Mutete, MBChB (Livingstone University Teaching Hospital) Dr. Mutete has nothing to disclose.
Coolwe Namangala Dr. Namangala has nothing to disclose.
Alexandra Peloso, MD Dr. Peloso has nothing to disclose.
Faith Simushi, MD (University Teaching Hospital) Dr. Simushi has received research support from American Neurological Association - ANA.
Leroy Yankae, MD Leroy Yankae has nothing to disclose.
Stanley Zimba, MBBS (University Teaching Hospital) Dr. Zimba has nothing to disclose.
Madalitso Nthere, MBBS Dr. Nthere has nothing to disclose.
Emmanuel Mukambo, MD Dr. Mukambo has nothing to disclose.
Theresa Shankanga (University of Zambia, ridgeway campus) Miss Shankanga has nothing to disclose.
Diwell Mwansa (UNZA Ridgeway campus) Diwell Mwansa has nothing to disclose.
Musisye Luchembe Musisye Luchembe has nothing to disclose.
Taonga Msimuko, MD The institution of an immediate family member of Dr. Msimuko has received research support from Africa Development Bank.
Tamia Banda, Jr., MBBS Miss Banda has nothing to disclose.
Ndonji Chiwaya, MD Ndonji Chiwaya has nothing to disclose.
Deanna Saylor, MD, MHS (Johns Hopkins Hospital) Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.